MRVI
Maravai LifeSciences Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.32
−0.68%Aug 13, 2026, 07:34 UTC
Dimensional Fund Advisors LP increased its stake in Maravai LifeSciences Holdings, Inc. by 64.8% during the quarter, acquiring 558,050 additional shares, according to a Form 13F filing.
Source:Aug 6, 2026, 20:01 UTC
Maravai LifeSciences reported financial results for the second quarter ended June 30, 2026, with quarterly revenue of $51.4 million, a net loss of $21.6 million, and adjusted EBITDA of $8.7 million, and raised its full-year 2026 adjusted EBITDA guidance to $33 million to $35 million.
Jun 16, 2026, 13:02 UTC
TriLink, part of Maravai LifeSciences, opened a GMP enzyme manufacturing facility in Jupiter, Florida.
Source:Jun 3, 2026, 12:30 UTC
Maravai LifeSciences subsidiaries entered into a new credit agreement with a $150 million term loan facility and a $30 million revolving credit facility, using borrowings and cash on hand to prepay outstanding debt, extending maturity to 2032.
Source: